ZIP codes matter when it comes to severe COVID-19

COVID-19 has sent nearly 900,000 Americans to the hospital in the past two years. A new study shows that the ZIP codes they came from had a lot to do with how sick they were when they got to the hospital, and how much care they needed once they were there.
But those differences disappeared by the time their stays were done — whether they left the hospital alive or dead.
The new findings, published in the Annals of Internal Medicine, show the importance of social and economic inequality in the way the pandemic is playing out — including how early in their illness people seek or get access to care.
Even after the researchers took into account the underlying health of each person they studied, the social vulnerability index, or SVI, of their home ZIP code still made a difference. SVI combines multiple factors to create a score based on such things as a local area’s average income, education level and household density to the percentage of households led by single parents, or where English is not the primary language.
The findings could help policymakers target less-privileged areas with more services to prevent and respond to COVID-19 cases; SVI has already been used by the state of Michigan, and other states, to prioritize COVID vaccination outreach.
The study also shows the role of hospitals in equalizing outcomes for people from unequal backgrounds.

Read more →

'I saw my daughter's heart rate reach 280bpm'

A mother has spoken of the moment she saw her two-year-old daughter’s heart rate reach 280 beats per minute before she was diagnosed with a rare genetic condition.Evelyn, from Mountsorrel in Leicestershire, has Brugada syndrome – a condition that affects the way electrical signals pass through the heart.She has since been fitted with a defibrillator insider her abdomen, which has been triggered 12 times, her mum Emma said.Emma is now calling for further genetic heart screening to be made available to young children.”We could have lost Evelyn at any point, so it’s like it’s a ticking time bomb,” she said.Digital journalists: Navtej Johal and Alex ThorpFollow BBC East Midlands on Facebook, Twitter, or Instagram. Send your story ideas to eastmidsnews@bbc.co.uk.

Read more →

The C.D.C. isn’t publishing large portions of the Covid data it collects.

For more than a year, the Centers for Disease Control and Prevention has collected data on hospitalizations for Covid-19 in the United States and broken it down by age, race and vaccination status. But it has not made most of the information public.When the C.D.C. published the first significant data on the effectiveness of boosters in adults younger than 65 two weeks ago, it left out the numbers for a huge portion of that population: 18- to 49-year-olds, the group the data showed was least likely to benefit from extra shots, because the first two doses already left them well-protected.The agency recently debuted a dashboard of wastewater data on its website that will be updated daily and might provide early signals of an oncoming surge of Covid cases. Some states and localities had been sharing wastewater information with the agency since the start of the pandemic, but it had never before released those findings.Two full years into the pandemic, the agency leading the country’s response to the public health emergency has published only a tiny fraction of the data it has collected, several people familiar with the data said.Much of the withheld information could help state and local health officials better target their efforts to bring the virus under control. Detailed, timely data on hospitalizations by age and race would help health officials identify and help the populations at highest risk. Information on hospitalizations and death by age and vaccination status would have helped inform whether healthy adults needed booster shots. And wastewater surveillance across the nation would spot outbreaks and emerging variants early.Without the booster data for 18- to 49-year-olds, the outside experts whom federal health agencies look to for advice had to rely on numbers from Israel to make their recommendations on the shots.Kristen Nordlund, a spokeswoman for the C.D.C., said the agency has been slow to release the different streams of data “because basically, at the end of the day, it’s not yet ready for prime time.” She said the agency’s “priority when gathering any data is to ensure that it’s accurate and actionable.”Another reason is fear that the information might be misinterpreted, Ms. Nordlund said.Dr. Daniel Jernigan, the agency’s deputy director for public health science and surveillance said the pandemic exposed the fact that data systems at the C.D.C., and at the state levels, are outmoded and not up to handling large volumes of data. C.D.C. scientists are trying to modernize the systems, he said.

Read more →

The Ross procedure leads to improved survival in adults undergoing aortic valve surgery

The “Ross procedure” may be a more favorable option for aortic valve replacement among patients under 50 years old than more standard mechanical or biological replacements, according to a new study from The Mount Sinai Hospital in New York City.
The research, published in the February 21 issue of the Journal of American College of Cardiology, is the first to compare the Ross procedure to the other options, and shows that it leads to improved survival and better outcomes in younger adults.
“Not only was survival better than after biological or mechanical aortic valve replacement, it was also identical to the matched U.S. general population. To this day, this is the only operation that has ever been shown to restore survival after aortic valve replacement in young adults,” says lead author Ismail El-Hamamsy, MD, PhD, Mount Sinai Randall B. Griepp, MD Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai and Director of Aortic Surgery for the Mount Sinai Health System. “This is a huge deal because it demonstrates the impact of valve choice in the long term. However, there is an important word of caution: the Ross procedure is a more complex operation and should only be performed in Ross centers of excellence. When done in that setting, this represents a major breakthrough for young patients with aortic valve disease, including young women contemplating pregnancy.”
The aortic valve controls blood flow from the heart into the aorta, the main artery that feeds blood to most of the body. When the valve doesn’t work correctly, patients may need a replacement to preserve function of the heart muscle and prevent issues such as heart failure or sudden cardiac death. The standard open-heart procedures for repair include mechanical valve replacement — which uses a manufactured valve that requires patients to take life-long blood thinners to prevent stroke, as well as make some lifestyle modifications such as avoiding contact sports that may lead to falls and bruising — or a biological aortic valve replacement from a human or animal donor, which may last up to 20 years, but requires earlier reoperation in younger patients than a mechanical valve. The Ross procedure is a more complex operation where a surgeon replaces the diseased aortic valve with the patient’s own living pulmonary valve, which is a mirror image of a normal aortic valve. This is the fundamental difference between the Ross procedure and a biological or mechanical valve replacement, which is a critical factor for successful long-term outcomes in patients.
Researchers analyzed records of 1,302 patients between 18 and 50 years old who underwent first-time elective aortic valve replacement surgery in California and New York State between January 1, 1997, and December 31, 2014. Patients were equally divided into three categories using propensity-matched analysis to eliminate any baseline differences; one-third of them had the Ross procedure, one-third had biological valve replacement, and the rest had mechanical valve replacement. The retrospective study compared the long-term survival and risk of valve-related complications (including stroke, major bleeding, reoperation, and acute endocarditis) according to the surgical procedure.
Investigators looked at outcomes 15 years post-procedure and found that patient survival was significantly better after the Ross procedure. At 15 years, overall mortality was more than twofold higher if the patients received a biological or mechanical aortic valve versus a Ross procedure. Furthermore, survival after the Ross procedure (93 percent survival at 15 years) was identical when compared to people of the same age and sex in the U.S. general population who did not have aortic valve replacement surgery. In terms of valve-related complications, the Ross procedure was associated with a significantly lower risk of stroke or major bleeding than a mechanical valve (3.8 percent after a Ross procedure versus 13 percent after a mechanical valve at 15 years). Similarly, the Ross procedure was associated with significantly fewer reoperations (17 percent versus 30 percent at 15 years) and endocarditis — an infection of the heart tissue — than a biological valve (2.3 percent versus 8.5 percent at 15 years). At 15 years, however, the risk of reoperation was higher after a Ross procedure than after mechanical valve replacement (17 percent versus 7.4 percent at 15 years).
The study also looked at 30-day mortality after the occurrence of any valve-related complication, including stroke, major bleeding, endocarditis, or reoperation. Researchers found the lowest mortality was linked to reoperation (1 percent), whereas if patients had a stroke, major bleeding, or endocarditis, the associated mortality was at least three times higher (5.6 percent after a stroke and 13.5 percent after endocarditis).
“This study demonstrates that while there is a definite risk of reoperation after the Ross procedure, the associated risk is low. In other words, this should be seen as a bump on the road, rather than the end of the road. In contrast, if patients suffer a stroke, hemorrhage, or infection, the consequences are much more dire,” explains Dr. El-Hamamsy. “Patients should be given all this data so they can make truly informed decisions about these major life events. Ultimately, the day, the Ross procedure is associated with better survival and fewer complications.”
The authors hope that this will further encourage the development of regional Ross centers of excellence to improve patient access and safety. Furthermore, Dr. El-Hamamsy’s team, which has the largest experience worldwide with this operation, are working on further improving the durability of the Ross procedure so that even fewer patients ever need a reoperation.

Read more →

COVID-19 genetic risk variant protects against HIV, study finds

The genetic variants we are born with can increase or decrease our risk of falling seriously ill with COVID-19. The major genetic risk variant for severe COVID-19, one we inherited from Neandertals, is surprisingly common. This raises the question whether it may actually be of advantage to carry this variant. A study by Hugo Zeberg, a researcher at the Max Planck Institute for Evolutionary Anthropology (MPI-EVA) in Germany and Karolinska Institutet in Sweden, now shows that the same gene variant that increases the risk of falling seriously ill with COVID-19 protects from another serious disease — it reduces a person’s risk of contracting HIV by 27 percent. This study is published in Proceedings of the National Academy of Sciences.
Some people become seriously ill when infected with SARS-CoV-2 while others have only mild symptoms or no symptoms at all. In addition to risk factors such as advanced age and chronic diseases, like diabetes, our genetic heritage also contributes to our individual COVID-19 severity risk.
In the autumn of 2020, Hugo Zeberg at Karolinska Institutet and MPI-EVAand Svante Pääbo at MPI-EVA showed that we inherited the major genetic risk factor for severe COVID-19 from Neandertals. In the spring of 2021, the same researcher duo studied this variant in ancient human DNA and observed that its frequency has increased significantly since the last ice age. In fact, it has become unexpectedly common for a genetic variant inherited from Neandertals. Hence, it may have had a favourable impact on its carriers in the past. “This major genetic risk factor for COVID-19 is so common that I started wondering whether it might actually be good for something, such as providing protection against another infectious disease,” says Hugo Zeberg, who is the sole author of the new study in PNAS.
The genetic risk factor is located in a region on chromosome 3 that consists of many genes. There are several genes in its vicinity that encode receptors in the immune system. One of these receptors — CCR5 — is used by the HIV virus to infect white blood cells. Zeberg found that people who carried the risk factor for COVID-19 had fewer CCR5 receptors. This led him to test whether they also had a lower risk of becoming infected with HIV. By analysing patient data from three major biobanks (FinnGen, UK Biobank and Michigan Genomic Initiative) he found that carriers of the risk variant for COVID-19 had a 27 percent lower risk of contracting HIV. “This shows how a genetic variant can be both good and bad news: Bad news if a person contracts COVID-19, good news because it offers protection against getting infected with HIV,” says Zeberg.
However, since HIV only arose during the 20th century, protection against this infectious disease cannot explain why the genetic risk variant for COVID-19 became so common among humans as early as 10,000 years ago. “Now we know that this risk variant for COVID-19 provides protection against HIV. But it was probably protection against yet another disease that increased its frequency after the last ice age,” Zeberg concludes.
Story Source:
Materials provided by Max Planck Institute for Evolutionary Anthropology. Note: Content may be edited for style and length.

Read more →

Covid: Chris Whitty urges people to continue to self-isolate if positive

England’s Chief Medical Officer Chris Whitty has urged people to continue to self-isolate if they test positive for the coronavirus in the coming weeks.From Thursday, people with a positive test will no longer need to self-isolate under law, but will still be advised to stay at home.After 1 April, people with Covid symptoms will be asked to “exercise personal responsibility” in their decisions over interactions with other people.Prof Whitty said that self-isolating is “standard public health advice” for any significant and highly transmissible infection.

Read more →

Paul Farmer, Pioneer of Global Health, Dies at 62

As a medical student, Dr. Farmer decided to build a clinic in Haiti. It grew into a vast network serving some of the world’s poorest communities.Paul Farmer, a physician and anthropologist who sought to bring high-quality health care to some of the world’s poorest people, died on Monday in Rwanda. He was 62.Partners in Health, the global public health organization that Dr. Farmer co-founded, announced his death in a statement that did not specify the cause. Dr. Farmer previously lived in Rwanda and spent decades focused on improving its health care system.Dr. Farmer gained public renown thanks largely to “Mountains Beyond Mountains: The Quest of Dr. Paul Farmer, a Man Who Would Cure the World,” a 2003 book by Tracy Kidder. It told Dr. Farmer’s life story and celebrated his devotion to helping the neediest.After he graduated from college in 1982, Dr. Farmer lived for years among Haiti’s poorest farmers, sleeping for only one or two hours a night as he set up a new medical infrastructure.He eventually returned to the United States to attend Harvard Medical School and earn a degree in anthropology, but he continued to spend much of his time in Cange, the community where he built his first clinic, returning to Harvard for exams and laboratory work.Over the years that followed, Dr. Farmer raised millions of dollars, which were funneled to an ever-expanding network of community health facilities. He had a contagious enthusiasm; when Thomas White, who owned a large construction company in Boston, asked to meet him, he insisted that the meeting take place in Haiti.Dr. Paul Farmer speaking with an HIV patient, Altagrace Cenatus, at the Partners in Health hospital, in 2003.Angel Franco/The New York TimesMr. White became a core donor, and contributed $1 million in seed money to Partners in Health, which Dr. Farmer founded in 1987, along with Ophelia Dahl, another volunteer in Haiti, and a former Duke classmate, Todd McCormack.The clinic in Haiti, at first a single room, grew, over the years, into a hospital and adjoining nursing school, serving a community of more than 150,000 people.Dr. Farmer became a public health luminary, the subject of a 2017 documentary, “Bending the Arc,” and the author of 12 books. The latest, “Fevers, Feuds and Diamonds: Ebola and the Ravages of History,” sought to dispel the more lurid misconceptions about the illness and focus on the dearth of health care essentials in upper West Africa.“For all their rainfall,” Dr. Farmer wrote, “their citizens are stranded in the medical desert.”In 2020, Dr. Farmer received the $1 million Berggruen Prize, given annually to a person whose ideas have “profoundly shaped human self-understanding and advancement in a rapidly changing world.”The chairman of the prize committee, Kwame Anthony Appiah, said Dr. Farmer had “reshaped our understanding” of “what it means to treat health as a human right and the ethical and political obligations that follow.”Dr. Farmer’s survivors include his wife, Didi Bertrand Farmer, a researcher for Partners in Health, and their children, Elizabeth, Catherine and Sebastian.A full obituary will be published soon.

Read more →

Coronavirus: PM announces end of Covid restrictions in England

Boris Johnson has told MPs about his plans to scrap all remaining Covid legal restrictions in England.This will start with ending the need to self-isolate after a positive test from Thursday and will also see an end to routine contact tracing.His statement in the Commons came after a Cabinet meeting, amid reports of tensions over the future of free lateral flow tests, and ahead of a press conference on Monday evening.He had told MPs ahead of the recess about his intention to end the rules “a full month” earlier than the previous planned date on 24 March.Live coverage: Johnson announces end to Covid self-isolation from Thursday

Read more →

Newly developed radio-labeled molecule enables real-time imaging of innate immune activity

Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow a non-invasive approach to monitor inflammation in real time by positron emission tomography (PET) imaging.
The preclinical study, published today in Nature Biotechnology, takes advantage of new chemistry techniques to synthesize 4-[18F]Fluoro-1-Naphthol([18F]4FN) as a novel reporter of myeloperoxidase (MPO) activity — a key enzyme active in the innate immune response. The molecule may be able to pinpoint areas of inflammation in a variety of clinical settings, such as inflammatory diseases, infections and immunotherapy-related side effects.
“There has been a long-standing interest in imaging inflammation and redox in general, but most current approaches generate high levels of background noise from biological processes that generate lower-energy radicals,” said corresponding author David Piwnica-Worms, M.D., Ph.D., chair of Cancer Systems Imaging. “Our molecule is tuned toward inflammation mediated by high-energy radicals, offering the potential to selectively monitor activation of innate immunity.”
The innate immune response is the body’s first line of defense against invading pathogens. In contrast to the adaptive immune response, innate immunity is nonspecific and acts broadly against infections or foreign agents. Innate immunity is largely driven by myeloid cells, including neutrophils, macrophages and natural killer (NK) cells.
Myeloperoxidase is a highly conserved feature of the innate immune response across myeloid cells. This proinflammatory enzyme is activated by hydrogen peroxide to produce a variety of high-energy radicals that are used to eliminate pathogens.
Co-led by Federica Pisaneschi, Ph.D., assistant professor, and Seth T. Gammon, Ph.D., associate professor of Cancer Systems Imaging, the research team focused on MPO activity to develop a redox-tuned reporter specific to innate immune activity. Using newly developed chemistry techniques, the team was able to synthesize [18F]4FN as a labeled molecule to selectively bind nearby proteins and cells when [18F]4FN has been oxidized by MPO plus hydrogen peroxide, but not hydrogen peroxide alone.
The researchers evaluated the potential uses of [18F]4FN as an in vivo PET imaging tool in several laboratory models of inflammation. The molecule was able to successfully highlight inflammation from acute toxic shock, arthritis and contact dermatitis, ailments known to be mediated by activation of innate immunity. In addition, their results suggest [18F]4FN is a more specific and robust reporter of inflammation than other clinically utilized PET imaging agents, such as fluorodeoxyglucose ([18F]FDG).
“We need to verify this PET imaging agent in clinical studies, but it certainly has the potential for broad applications that could benefit patients across all kinds of diseases and clinical scenarios,” Piwnica-Worms said. “A tool like this could be used to identify multi-focal hotspots of inflammation, allowing physicians to intervene before disease progression or to follow the resolution of symptoms during therapy.”
The research team is in discussions with clinical collaborators to test specific applications of [18F]4FN. An initial study, now under Food and Drug Administration review for Investigational New Drug registration and Institutional Review Board approval, will evaluate [18F]4FN as an early biomarker of immune-related adverse events in patients being treated with immune checkpoint inhibitors.
The research was supported by the Gerald Dewey Dodd Jr. Endowed Distinguished Chair, The University of Texas System Faculty STARs Program, and the National Cancer Institute (P30 CA016672).
Additional collaborating authors include Vincenzo Paolillo, Ph.D., and Sarah A. Qureshy, both of Cancer Systems Imaging. Pisaneschi, Gammon and Piwnica-Worms are inventors on a patent application related to the compounds and methods described in this study. The remaining authors have no conflicts of interest.

Read more →

Uproar Over ‘Crack Pipes’ Puts Biden Drug Strategy at Risk

President Biden has made “harm reduction” a central pillar of his plan to fight a record number of drug-related deaths, but a conservative backlash is threatening the effort.WASHINGTON — President Biden came into office vowing to make “harm reduction” — a public health approach geared toward helping drug users stay safe rather than abstain — a central pillar of his drug policy agenda, at a time when illicit fentanyl has driven a surge in overdose deaths.Instead, his strategy is in danger of being derailed by a Washington drama over “crack pipes” that is more about political gamesmanship than public health. The clash is a revival of decades-old fights over clean needle exchange programs that addiction experts hoped had finally been laid to rest.Lawmakers of both parties introduced legislation last week to bar federal funding for “drug paraphernalia” in response to a story in the Washington Free Beacon, a conservative website, asserting that federally funded addiction treatment programs would distribute pipes for smoking crack cocaine as part of “safe smoking kits.” In response, the White House said tax dollars would not be spent on pipes.But with the Beacon story ricocheting around the conservative ecosystem — amplified by Republican including Senators Tom Cotton of Arkansas and Ted Cruz of Texas — Congress is pursuing plans not only to bar federal funding for “crack pipes,” but to impose restrictions on a new program that would have, for the first time, allowed federal funds to be spent on sterile needles for “syringe services” programs.Multiple studies have shown that distributing new syringes to drug users reduces the spread of blood borne diseases among drug users, including H.I.V., hepatitis C and lethal heart infections. The programs also provide naloxone, the overdose-reversing drug, and connect drug users to treatment and other resources.Some harm reduction programs do include sterile pipes — which are used for smoking methamphetamine and fentanyl as well as crack cocaine — in such kits, with the intent of preventing infectious disease or injury in drug users who might otherwise rely on contaminated paraphernalia. Harm reduction workers often try to steer users toward smoking rather than injecting, which poses a higher risk of infection and overdose.But there is no evidence that the Biden administration intended to pay for distribution of pipes. Nonpartisan fact checkers have debunked the claim.“This is tragic — we’ve gone full circle,” said Donna E. Shalala, who fought — and lost — a battle to get federal funding for needle exchange programs in the 1990s, when she was President Bill Clinton’s health secretary. Harm reduction, she added, “is a respectable, important strategy.”Yet even now, decades into a pervasive opioid epidemic that has led to hundreds of thousands of overdose deaths from prescription painkillers, heroin and synthetic fentanyl, which now also frequently turns up in stimulants like methamphetamine and cocaine — and many more from infectious diseases stemming from drug use — addiction experts say the backlash is not entirely surprising.As Regina LaBelle, an addiction policy expert at Georgetown University and the architect of Mr. Biden’s harm reduction policy, said in an interview: “We knew it wasn’t going to be easy.”Roughly 100,000 Americans died last year from drug overdoses, according to preliminary data from the Centers for Disease Control and Prevention — a record number that has more than doubled since 2015.Emergency personnel responded to a call in 2020 for a drug overdose in Paterson, N.J.Chang W. Lee/The New York TimesThe crack pipe fracas arrived just as experts thought they were making progress in getting politicians, including conservative Republicans, to accept harm reduction as a valid strategy. A case in point is former Vice President Mike Pence.In 2015, when Mr. Pence was the governor of Indiana, H.I.V. was spreading with terrifying speed among intravenous drug users in Scott County, a rural pocket of the state. Local, state and federal health officials were urging Mr. Pence to allow clean needles to be distributed to slow the outbreak, but Indiana law made it illegal to possess a syringe without a prescription.Mr. Pence, a steadfast conservative, was morally opposed to syringe exchanges on the grounds that they enabled drug abuse. But when the county sheriff urged him to allow the programs, Mr. Pence prayed about it — then signed an executive order doing so. It helped slow the H.I.V. outbreak to a trickle.Nearly two decades earlier, in 1998, Mr. Clinton blocked federal funding for clean needle programs, despite a personal appeal from Ms. Shalala. In an interview, she said Mr. Clinton had buckled under pressure from Democrats in Congress, who worried they would lose elections by being portrayed as soft on crime.Undeterred, Ms. Shalala encouraged philanthropies to finance needle exchange programs, and instructed National Institutes of Health experts to conduct trainings on needle exchange. Mr. Clinton later said he regretted his decision.When Mr. Biden was elected, addiction experts were elated. The American Rescue Plan, the coronavirus relief package he signed into law last year, set aside $30 million for a new Harm Reduction Grant Program to “support community-based overdose prevention programs, syringe services programs, and other harm reduction services.”It was the first time Congress had created a specific grant for harm reduction programs — which often run on shoestring budgets — and the grant program was exempt from a longstanding ban, renewed annually in spending measures, on using tax dollars to purchase clean needles. Some experts thought the ban might be lifted for good.“We finally got to a place where that ban was going to be lifted, we would see sustainability, we would see a massive shift in our current state of infectious disease,” said Chad Sabora, vice president of government and public relations at the Indiana Center for Recovery, a treatment center. He called the new controversy “heartbreaking.”Safe smoking kits are often distributed by syringe service programs, and often include glass stems, which function as pipes, as well as lip balm, alcohol swabs, rubber tips and other items to protect against mouth sores and cuts that can spread disease. The guidelines for the new federal grant program are not specific about it about whether the kits can include pipes.The law is murky; a 1986 law classifies crack pipes (but not needles) as drug paraphernalia and makes it illegal to sell or ship them. Ms. LaBelle said that law, and similar state laws, arguably could preclude the government from funding the glass stems that serve as pipes.After the uproar over the Free Beacon article, the White House Press Secretary, Jen Psaki, said glass pipes were “never a part of the kit,” insisting the story was untrue.Conservatives accused the White House of reversing itself.“The Biden administration is in cleanup mode because they got caught funding crack pipe distribution,” Mr. Cotton wrote on Twitter.Many addiction experts saw the political blowup over crack pipes as having racist undertones. Dahlia Heller, an addiction policy expert at Vital Strategies, a global nonprofit organization that supports harm reduction, said the Beacon story was “calling up a racist trope, very clearly, of Black people smoking crack. It was dog whistling a 1980s war on drugs.”Mr. Cotton, who leads a bipartisan commission to combat the trafficking of synthetic opioids — particularly fentanyl — was among those who responded by introducing legislation to ban funding for drug paraphernalia. Yet even as he expressed his outrage over crack pipes, he issued a commission report citing needle exchange programs as a well-documented way to get people struggling with drug abuse into treatment.Drug treatment programs funded by the federal government also include the use of naloxone, or Narcan, which can save drug users who overdose.Whitney Curtis for The New York TimesMr. Cotton’s spokeswoman, Caroline Tabler, said the commission did not suggest expanding needle exchange programs. Mr. Cotton opposes syringe services programs, which he believes “would enable drug use, empower drug suppliers, and harm Americans,” she said. Mr. Cotton is not the only lawmaker parsing his words. Senator Joe Manchin III, Democrat of West Virginia, reacted to the Beacon story by joining with Senator Marco Rubio, Republican of Florida, to introduce the PIPES Act, which would bar federal funds from being used to purchase “drug paraphernalia, such as crack pipes or needles.” The initials stand for Preventing Illicit Paraphernalia for Exchange Systems.Mr. Manchin’s home state is West Virginia, a longtime epicenter of the opioid crisis. The state capital, Charleston shuttered its harm reduction program in 2018; by the end of the year Charleston was leading the state in overdose deaths. West Virginia is among a number of states that have recently passed laws making it more difficult for syringe services to operate, as state lawmakers continue to oppose them on the grounds that they enable drug use and draw community complaints.“Manchin was never going to save us, but now it looks like he is going to bury us,” said Joe Solomon, a founder of Solutions Oriented Addiction Response, or SOAR, a which ran a syringe exchange program in Charleston until last year, when the City Council imposed restrictions that effectively forced its closure.Yet in 2016, Mr. Manchin praised President Barack Obama for an initiative that included needle exchange programs. That program was the result of a compromise: after nearly 30 years of an outright ban on any funding for needle exchange programs, Congress agreed to pay for program operations — but not the needles themselves — so long as state and local authorities, in consultation with the C.D.C., determined that a community was in danger of an infectious disease outbreak.The Manchin-Rubio bill would retain the current language about the C.D.C., but would extend the ban on purchasing needles to the American Rescue Plan funding. Its fate, and the fate of bills like it, is uncertain. Mr. Rubio tried unsuccessfully to force senators to vote on the measure before passing a spending resolution last week, and Congress is now on recess until the end of the month.In the meantime, Ms. LaBelle said, she and other experts have some work to do.“We have a lot of ingrained ideas about substance use and people are working hard to make sure that the general public understands what addiction is, what a substance use disorder is — that it’s not a moral failing,” she said. “But we’re still not at that point.”

Read more →